| Not Yet Recruiting | EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases NCT07448376 | Huazhong University of Science and Technology | — |
| Recruiting | Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma NCT06919939 | University of Miami | Phase 2 |
| Not Yet Recruiting | The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia NCT07287228 | Institute of Hematology & Blood Diseases Hospital, China | Phase 1 / Phase 2 |
| Recruiting | Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic NCT07105579 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Recruiting | Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblas NCT06356883 | Université de Sherbrooke | Phase 2 |
| Recruiting | CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia NCT06622694 | Institute of Hematology & Blood Diseases Hospital, China | Phase 1 |
| Recruiting | Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML NCT06737523 | The First Affiliated Hospital of Xiamen University | Phase 1 |
| Not Yet Recruiting | Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia Post-transplant Relapse Prevent NCT06754540 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Recruiting | ''Comparative Evaluation of Change in Bite Force and Levels of Bone Turnover Markers CTX and BALP in Hyperdive NCT06456827 | Postgraduate Institute of Dental Sciences Rohtak | N/A |
| Recruiting | Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool NCT06618755 | University Hospital, Montpellier | N/A |
| Recruiting | Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transp NCT06686108 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Recruiting | Autologous CAR-T Cells Targeting B7-H3 in PDAC NCT06158139 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Recruiting | Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells NCT06347068 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Recruiting | ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells NCT06090864 | UNC Lineberger Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Recruiting | Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC NCT06096038 | UNC Lineberger Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Not Yet Recruiting | Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion NCT06180499 | Assistance Publique - Hôpitaux de Paris | Phase 1 / Phase 2 |
| Unknown | Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study NCT05927558 | Gruppo Italiano Malattie EMatologiche dell'Adulto | — |
| Active Not Recruiting | Isa-Pom-Dex in Elderly/Frail Subjects With RRMM NCT05911321 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Recruiting | Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder NCT06105853 | Central Institute of Mental Health, Mannheim | N/A |
| Unknown | Comparison of Retention Characteristics of Immediate vs Delayed Retainer Delivery Using 3D Digital Model Analy NCT06292364 | Postgraduate Institute of Dental Sciences Rohtak | N/A |
| Recruiting | Comparison of Laparoscopic and Open Inguinal Hernia Repair in Elderly Patients NCT06417346 | Mehmet Eşref Ulutaş | N/A |
| Recruiting | Comparison of Mesh Fixation and Non-Fixation in eTEP NCT06417359 | Mehmet Eşref Ulutaş | N/A |
| Unknown | Observational Trial Evaluating Elevated Factor VIII Related Labs as a Biomarker for Incomplete Relapse Recover NCT05926167 | Dignity Health Medical Foundation | — |
| Terminated | A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies NCT05861947 | Aurigene Discovery Technologies Limited | Phase 1 |
| Withdrawn | Relapse Prevention in Stimulant Use Disorder NCT04553263 | University of California, Los Angeles | EARLY_Phase 1 |
| Withdrawn | Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia NCT05232227 | University of California, San Francisco | Phase 2 / Phase 3 |
| Completed | Does the Mesh Have to be Fixed in Laparoscopic eTEP Repair of Bilateral Inguinal Hernia? NCT06070207 | Mehmet Eşref Ulutaş | N/A |
| Completed | Does the Mesh Have to be Fixed in Laparoscopic eTEP Repair of Inguinal Hernia? NCT06070142 | Mehmet Eşref Ulutaş | N/A |
| Completed | Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-te NCT05591703 | Spark Biomedical, Inc. | — |
| Unknown | : "Comparative Evaluation of 3 Dimensional Changes of Dentition in Post Orthodontic Patients With Immediate vs NCT05879588 | Postgraduate Institute of Dental Sciences Rohtak | N/A |
| Unknown | "Comparative Evaluation of 3 Dimensional Changes of Dentition in Post Orthodontic Patients With Immediate vs D NCT05879601 | Postgraduate Institute of Dental Sciences Rohtak | N/A |
| Unknown | "Comparative Evaluation of 3 Dimensional Changes of Dentition in Post Orthodontic Patients With Immediate vs D NCT05612932 | Postgraduate Institute of Dental Sciences Rohtak | N/A |
| Active Not Recruiting | The Effectiveness of 3 Orthodontic Fixed Retention Schemes on Post-treatment Stability and Gingival Recession NCT05926934 | University of Athens | N/A |
| Unknown | PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Cla NCT05137886 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Unknown | Ibrutinib Combined With Rituximab for Treatment of Relapsed Refractory MYD88 and CD79A/B (or CD79B Alone) DLBC NCT04994626 | Chinese Academy of Medical Sciences | Phase 2 |
| Unknown | Outcomes of Patients After Allo-HSCT With Decitabine and NAC NCT04945096 | The First Affiliated Hospital of Soochow University | Phase 3 |
| Active Not Recruiting | Study of the Impact on the Evolution of the Disease in the Medium Term of the Implementation of a System of Ex NCT04864626 | Centre Hospitalier Universitaire de Saint Etienne | — |
| Unknown | STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence After prostatectomy-a Prospective Ob NCT05455736 | Azienda Ospedaliero-Universitaria Careggi | — |
| Unknown | The Use of Immunohistochemical Staining for the Prediction of Wilms Tumour Progression and Recurrence NCT04758455 | Mansoura University | N/A |
| Completed | Clinical Effectiveness of Bonded Versus Vacuum-formed Retainers NCT04847323 | University of Sao Paulo | N/A |
| Unknown | Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leu NCT04674345 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Unknown | Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia NCT04723901 | Shenzhen University General Hospital | Phase 1 / Phase 2 |
| Unknown | Ingrown Toenails : Surgery Only Versus Surgery + Chemical Cauterization With TCA NCT04921540 | University Hospital, Caen | N/A |
| Unknown | MBRP + Vortioxetine VS MBRP on Preventing Relapse in Chronic MA Users NCT03830827 | Sir Run Run Shaw Hospital | Phase 4 |
| Completed | Comparison of Efficiency and Effectiveness of Two Types of Bonded Orthodontic Retainers: an RCT. NCT05250765 | University Hospital, Ghent | N/A |
| Unknown | Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus Relapse NCT04662138 | Alexandria University | — |
| Completed | Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in P NCT04139434 | Newave Pharmaceutical Inc | Phase 1 |
| Terminated | HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis NCT03456817 | AHS Cancer Control Alberta | Phase 2 |
| Recruiting | Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM NCT04176718 | Andrew Yee, MD | Phase 2 |
| Unknown | Biomarkers of P. Vivax Relapse NCT04228315 | Armed Forces Research Institute of Medical Sciences, Thailand | N/A |
| Completed | Relapse and Failure Rates Between CAD/CAM and Conventional Fixed Retainers NCT05915273 | Nourhan M.Aly | N/A |
| Completed | Ketamine IV Classic Protocol : Five Years Follow up NCT04824157 | Sheba Medical Center | — |
| Completed | Long-term Follow-up After Surgical Treatment for GERD (Gastroesophageal Reflux Disease) NCT04182178 | Karolinska Institutet | — |
| Completed | Stress-related Predictor Profiles in Human Addiction NCT03810924 | Central Institute of Mental Health, Mannheim | N/A |
| Unknown | PET/MRI Study on the Neurological Mechanism of rTMS Treatment for Heroin Addiction NCT04086459 | Tang-Du Hospital | N/A |
| Unknown | Tri Association in Patient With Advanced Epithelial Ovarian Cancer in Relapse NCT04015739 | ARCAGY/ GINECO GROUP | Phase 2 |
| Unknown | Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignanc NCT03771222 | Chinese PLA General Hospital | Phase 2 |
| Withdrawn | Epacadostat, Cladribine and Cytarabine (ECC) in AML NCT03491579 | Insel Gruppe AG, University Hospital Bern | Phase 1 |
| Unknown | Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714 NCT03691077 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Unknown | Evaluation of Early Relapse After Mandibular Lengthening Surgery NCT03710512 | Universitair Ziekenhuis Brussel | — |
| Unknown | CAD/CAM Fixed Retainers vs. Conventional Multistranded Fixed Retainers in Orthodontic Patients. Comparison of NCT04389879 | University of Aarhus | N/A |
| Recruiting | IA Carboplatin + Radiotherapy in Relapsing GBM NCT03672721 | Université de Sherbrooke | Phase 1 / Phase 2 |
| Recruiting | Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease NCT05461820 | The First Affiliated Hospital with Nanjing Medical University | Phase 4 |
| Unknown | Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells NCT03236129 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Completed | Effectiveness of Two Types of Fixed Lingual Retainers in Preventing Mandibular Incisor Relapse NCT03881813 | Dow University of Health Sciences | N/A |
| Unknown | Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis NCT04380220 | Regina Elena Cancer Institute | — |
| Completed | A Study of Repetitive Transcranial Magnetic Stimulation in Bipolar Patients NCT03207048 | Guangzhou Psychiatric Hospital | N/A |
| Unknown | CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia NCT03275493 | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | Phase 1 / Phase 2 |
| Completed | CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma NCT03029338 | Institute of Hematology & Blood Diseases Hospital, China | Phase 1 |
| Withdrawn | Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation NCT03121079 | Peking University People's Hospital | N/A |
| Unknown | Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotrans NCT03297528 | Peking University People's Hospital | Phase 2 |
| Unknown | Chidamide Plus DCAG for Relapsed/Refractory AML NCT02886559 | Chinese PLA General Hospital | Phase 1 / Phase 2 |
| Unknown | Evaluation of a Psychoeducation Program for Families Caregivers of Schizophrenic Patients : Randomized Study i NCT03000985 | Centre Hospitalier Charles Perrens, Bordeaux | N/A |
| Unknown | RCT for the Effectiveness of 3 Orthodontic Retention Schemes on Post-treatment Stability and Gingival Recessio NCT02742493 | University of Athens | N/A |
| Completed | Evaluation of a Motion-Activated Refusal-Skills Training Video Game for Prevention of Substance Use Disorder R NCT03957798 | George Washington University | N/A |
| Completed | MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT NCT02673008 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Terminated | Ketamine for Relapse Prevention in Recurrent Depressive Disorder NCT02661061 | St Patrick's Hospital, Ireland | Phase 1 |
| Completed | Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies NCT02145403 | University of Michigan Rogel Cancer Center | Phase 1 / Phase 2 |
| Unknown | Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hod NCT02280993 | Marjolein Spiering | Phase 1 |
| Completed | Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma NCT01956695 | Institut Curie | Phase 2 |
| Completed | Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence NCT01874951 | Massachusetts General Hospital | Phase 2 |
| Completed | Cord Blood Transplantation in Severe Aplastic Anemia NCT01343953 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Completed | Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid C NCT02515084 | Centre Henri Becquerel | Phase 2 |
| Completed | fMRI Study of a Dual Process Treatment Protocol With Substance Dependent Adults NCT01320748 | Inova Health Care Services | N/A |
| Completed | Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort NCT01070719 | John F. Foley, MD | — |
| Terminated | ASCT for Relapsed APL After Molecular Remission NCT00907582 | Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Terminated | Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relaps NCT00882193 | University of Nebraska | EARLY_Phase 1 |
| Completed | TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma NCT00867568 | Giselle Sholler | Phase 1 |
| Completed | A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian C NCT01481701 | Jules Bordet Institute | Phase 2 |
| Terminated | Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer NCT00888810 | Centre Francois Baclesse | Phase 2 |
| Unknown | Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation NCT01941394 | National Research Center for Hematology, Russia | Phase 2 |
| Withdrawn | "The Evaluation of Stimulant Withdrawal" NCT00442923 | Aaron J. Janowsky | Phase 2 |
| Active Not Recruiting | Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta) NCT00368082 | Baylor College of Medicine | Phase 1 |
| Completed | Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes Infusion NCT00987987 | Assistance Publique - Hôpitaux de Paris | Phase 1 / Phase 2 |
| Unknown | Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combinatio NCT00299923 | University of Hamburg-Eppendorf | Phase 3 |
| Completed | Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multip NCT00306813 | University of Wuerzburg | Phase 1 / Phase 2 |
| Completed | A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients NCT00752518 | Janssen Pharmaceutical K.K. | Phase 1 / Phase 2 |
| Completed | Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission NCT04298619 | Federico II University | — |